Key result
Myocardial edema imaging with cardiac magnetic resonance defines the amount of myocardium at risk and refines prognosis estimates in patients with acute coronary syndromes.
CMR-based myocardial edema imaging provides excellent sensitivity for defining myocardium at risk and refining prognosis in acute coronary syndromes.
May aid ACS risk stratification; leaves open whether CMR edema imaging alters management or outcomes.
Acute coronary syndromes (ACS) continue to be the most common morbid condition of industrialized nations. The advent of and technical improvements in revascularization and medical therapy have led to a steady decline in mortality rates. However, many patients who suffer unstable angina or myocardial infarction require further testing and risk stratification to guide therapeutic selection and prognosis assignment. Myocardial edema imaging with cardiac magnetic resonance (CMR) affords the ability to define the amount of myocardium at risk, refine estimates of prognosis and provide guidance for therapies with excellent sensitivity compared with standard clinical markers. This review will discuss the rationale for edema imaging, how it is performed using CMR, and potential clinical applications.
No takes yet. Share an insight, caveat, or question.
Walls et al. (2011) conducted a review in Acute coronary syndromes. Myocardial edema imaging with cardiac magnetic resonance (CMR) was evaluated. Myocardial edema imaging with cardiac magnetic resonance defines the amount of myocardium at risk and refines prognosis estimates in patients with acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: